chrX-1290412-G-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_172245.4(CSF2RA):āc.549G>Cā(p.Leu183=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00048 in 1,613,696 control chromosomes in the GnomAD database, including 1 homozygotes. There are 322 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L183L) has been classified as Benign.
Frequency
Consequence
NM_172245.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.549G>C | p.Leu183= | synonymous_variant | 7/13 | ENST00000381529.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.549G>C | p.Leu183= | synonymous_variant | 7/13 | 1 | NM_172245.4 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00266 AC: 405AN: 152098Hom.: 1 Cov.: 32 AF XY: 0.00234 AC XY: 174AN XY: 74292
GnomAD3 exomes AF: 0.000721 AC: 181AN: 251178Hom.: 0 AF XY: 0.000597 AC XY: 81AN XY: 135742
GnomAD4 exome AF: 0.000252 AC: 368AN: 1461480Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 146AN XY: 727046
GnomAD4 genome AF: 0.00267 AC: 407AN: 152216Hom.: 1 Cov.: 32 AF XY: 0.00236 AC XY: 176AN XY: 74420
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Leu183Leu in exon 8 of CSF2RA: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.7% (32/4406) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs139093878). - |
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at